Pudhom
Kanitha Pudhom, Nonthaburi TH
Patent application number | Description | Published |
---|---|---|
20090076067 | PHARMACEUTICAL COMPOSITION COMPRISING AZARHODACYANINE COMPOUND AS ACTIVE INGREDIENT - The object of the invention is to provide pharmaceutical composition that can be used as a therapeutic and/or prophylactic agent. Particularly, the pharmaceutical composition of the invention has significant therapeutic effect and survival benefit for the disease caused by parasitic protozoa, and selective toxicity against the causative protozoa. The pharmaceutical composition comprises a compound represented by general formula (1). Particularly, the invention relates to a composition that is an effective therapeutic/prophylactic agent for malaria, | 03-19-2009 |
Khanitha Pudhom, Bangkok TH
Patent application number | Description | Published |
---|---|---|
20100113789 | MEDICINAL COMPOSITION FOR PREVENTION OR TREATMENT OF PARASITIC PROTOZOAN INFECTION - The present invention is to provide a medicinal composition for preventing or treating parasitic protozoan infections, having a high selective toxicity against parasitic protozoan infection, and a superior preventive or treating effect. A medicinal composition for preventing or treating parasitic protozoan infections comprises a compound shown by the following general formula (1) as an active ingredient | 05-06-2010 |
Khanitha Pudhom, Bangkok, CA US
Patent application number | Description | Published |
---|---|---|
20140296531 | Novel semi-synthetic small molecules for the treatment parasitic disease - Small molecule therapeutics for the treatment of parasitic diseases, in particular, semi-synthetic derivatives of the fugally-derived natural product merulin A for the treatment of African Sleeping Sickness. | 10-02-2014 |
Khanitha Pudhom, Santa Cruz, CA US
Patent application number | Description | Published |
---|---|---|
20150105453 | Methods for making and using novel semi-synthetic small molecules for the treatment parasitic disease - Small molecule therapeutics for the treatment of parasitic diseases, in particular, semi-synthetic derivatives of the fugally-derived natural product merulin A for the treatment of African Sleeping Sickness. | 04-16-2015 |